YU81503A - Postupak za proizvodnju farmaceutskog preparata sa niskom dozom, koji ima uniformnu raspodelu i snagu leka - Google Patents

Postupak za proizvodnju farmaceutskog preparata sa niskom dozom, koji ima uniformnu raspodelu i snagu leka

Info

Publication number
YU81503A
YU81503A YUP-815/03A YUP81503A YU81503A YU 81503 A YU81503 A YU 81503A YU P81503 A YUP81503 A YU P81503A YU 81503 A YU81503 A YU 81503A
Authority
YU
Yugoslavia
Prior art keywords
manufacturing
potency
pharmaceutical composition
drug distribution
low dose
Prior art date
Application number
YUP-815/03A
Other languages
English (en)
Inventor
Daniel Scott Gierer
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU81503A publication Critical patent/YU81503A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Opisan je postupak za proizvodnju farmaceutskog preprata koji ima uniformnu raspodelu i snagu, kojikoristi silicijum-dioksid za smanjenje gubitka aktivnog sastojka za vreme proizvodnog procesa. Postupak je posebno koristan za proizvodnju preparata tablete sa niskom dozom.
YUP-815/03A 2001-05-01 2002-03-13 Postupak za proizvodnju farmaceutskog preparata sa niskom dozom, koji ima uniformnu raspodelu i snagu leka YU81503A (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28784101P 2001-05-01 2001-05-01
PCT/IB2002/000766 WO2002087546A2 (en) 2001-05-01 2002-03-13 Method for manufacturing a low dose pharmaceutical composition

Publications (1)

Publication Number Publication Date
YU81503A true YU81503A (sh) 2006-08-17

Family

ID=23104578

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-815/03A YU81503A (sh) 2001-05-01 2002-03-13 Postupak za proizvodnju farmaceutskog preparata sa niskom dozom, koji ima uniformnu raspodelu i snagu leka

Country Status (44)

Country Link
US (2) US7037530B2 (sh)
EP (1) EP1383482B1 (sh)
JP (1) JP2004531537A (sh)
KR (1) KR100568380B1 (sh)
CN (1) CN1240375C (sh)
AP (1) AP2003002900A0 (sh)
AR (1) AR033288A1 (sh)
AT (1) ATE367152T1 (sh)
AU (1) AU2002236166B2 (sh)
BG (1) BG108297A (sh)
BR (1) BR0209283A (sh)
CA (1) CA2445519C (sh)
CZ (1) CZ20032959A3 (sh)
DE (1) DE60221238T2 (sh)
DK (1) DK1383482T3 (sh)
DO (1) DOP2002000389A (sh)
EA (1) EA005949B1 (sh)
EC (1) ECSP034826A (sh)
EE (1) EE200300537A (sh)
ES (1) ES2286226T3 (sh)
GE (1) GEP20053654B (sh)
GT (1) GT200200078A (sh)
HK (1) HK1065705A1 (sh)
HR (1) HRP20030858A2 (sh)
HU (1) HUP0401391A3 (sh)
IL (1) IL158390A0 (sh)
IS (1) IS6985A (sh)
MA (1) MA27017A1 (sh)
MX (1) MXPA03009391A (sh)
NO (1) NO20034709L (sh)
NZ (1) NZ528886A (sh)
OA (1) OA12596A (sh)
PA (1) PA8544401A1 (sh)
PE (1) PE20021137A1 (sh)
PL (1) PL366453A1 (sh)
PT (1) PT1383482E (sh)
SK (1) SK286536B6 (sh)
TN (1) TNSN03106A1 (sh)
TW (1) TWI264311B (sh)
UA (1) UA75135C2 (sh)
UY (1) UY27277A1 (sh)
WO (1) WO2002087546A2 (sh)
YU (1) YU81503A (sh)
ZA (1) ZA200307819B (sh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100636953B1 (ko) 2002-03-28 2006-10-19 화이자 프로덕츠 인코포레이티드 정제된 라소폭시펜 및 재결정화에 의한 라세미라소폭시펜의 정제 방법
PA8576201A1 (es) * 2002-07-10 2004-05-26 Pfizer Prod Inc Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco
US7799273B2 (en) 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes
US7444197B2 (en) 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
CN101448407A (zh) * 2006-05-17 2009-06-03 Wm.雷格利Jr.公司 制备食物产品的方法
FI20070521L (fi) 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20080351A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi matalan lääkepitoisuuden tabletin valmistamiseksi
US20100179110A1 (en) * 2006-12-20 2010-07-15 Mostafa Akbarieh Composition Containing a Bisphosphonic Acid in Combination with Vitamin D
US20080181972A1 (en) * 2007-01-29 2008-07-31 Valentina Amico Compositions and Methods for Maintaining, Strengthening, Improving, or Promoting Eye Health
LT2487166T (lt) 2007-02-23 2016-11-10 Gilead Sciences, Inc. Terapinių agentų farmakokinetinių savybių moduliatoriai
MX2010011963A (es) 2008-05-02 2010-12-06 Gilead Sciences Inc Uso de particulas trasportadoras solidas para mejorar la capacidad de procesamiento de un agente farmaceutico.
WO2009135946A1 (en) * 2008-05-09 2009-11-12 Atacama Labs Oy Method and apparatus for dry granulation
US20170065529A1 (en) 2015-09-09 2017-03-09 Boehringer Ingelheim International Gmbh Pharmaceutical dosage form for immediate release of an indolinone derivative
DK2299987T3 (en) * 2008-06-06 2018-05-22 Boehringer Ingelheim Int Pharmaceutical Capsule Dosage Form Containing A Suspension Formulation Of An Indolinone Derivative
WO2010094535A1 (en) * 2009-01-29 2010-08-26 Ucb Pharma, S.A. Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives
ES2520990T3 (es) * 2009-01-29 2014-11-12 Ucb Pharma, S.A. Composiciones farmacéuticas que comprenden derivados de 2-oxo-1-pirrolidina
US20140350945A1 (en) * 2013-05-22 2014-11-27 Professional Compounding Centers Of America System and Method for Validation of Pharmaceutical Composition Formulations
CN103830196A (zh) * 2014-03-14 2014-06-04 *** 一种酒石酸拉索昔芬分散片及其制备方法
CN106176649B (zh) * 2016-08-31 2020-04-17 北京斯利安药业有限公司 叶酸vb12片及其制备方法
JP2020510636A (ja) * 2017-02-17 2020-04-09 マサチューセッツ インスティテュート オブ テクノロジー 医薬錠剤を含む錠剤の製作のためのシステムおよび方法
CZ309820B6 (cs) * 2021-04-23 2023-11-08 Pro.Med.Cs Praha A.S. Způsob přípravy pevné lékové formy obsahující kompozici s nízkým obsahem účinné látky

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725555A (en) * 1967-08-01 1973-04-03 Ciba Geigy Corp Bactericidal compositions and method of killing bacteria using bis-(phenoxyphenyl) carbonates
US3725556A (en) * 1970-11-12 1973-04-03 D Hanssen Method of manufacturing rapidly disintegrating pharmaceutical tablets
US4013785A (en) * 1975-03-21 1977-03-22 Bristol-Myers Company Apap tablet containing fumed silica and process for manufacturing same
GB1570993A (en) * 1976-05-21 1980-07-09 Fisons Ltd Pharmaceutical tablet formulation
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
US5004613A (en) * 1987-07-27 1991-04-02 Mcneil-Ppc, Inc. Oral sustained release pharmaceutical formulation and process
US5047246A (en) * 1988-09-09 1991-09-10 Bristol-Myers Company Direct compression cyclophosphamide tablet
US5107331A (en) * 1989-03-07 1992-04-21 The Color Group Method and apparatus for producing half-tone separations at the same screen angle
US5376645A (en) * 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) * 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
US5976570A (en) * 1993-12-21 1999-11-02 Applied Analytical Industries, Inc. Method for preparing low dose pharmaceutical products
US5928668A (en) * 1993-12-21 1999-07-27 Applied Analytical Industries, Inc. Method for dry blend compression of medicaments
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
US5726168A (en) * 1995-10-12 1998-03-10 Eli Lilly And Company Lipophilic benzothiophenes
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
US5733578A (en) * 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
IL120266A (en) * 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
US5916916A (en) * 1996-10-10 1999-06-29 Eli Lilly And Company 1-aryloxy-2-arylnaphthyl compounds, intermediates, compositions, and methods
CA2218756A1 (en) * 1996-10-25 1998-04-25 Kristin Sue Marron Substituted benzo¢b!thiophene compounds having activity as selective estrogen receptor modulators
US6080427A (en) * 1997-04-17 2000-06-27 Bristol-Myers Squibb Company Cefadroxil monohydrate tablet formulation
ATE323110T1 (de) * 1997-07-01 2006-04-15 Pfizer Prod Inc Verfahren zur herstellung von einem cyclodextrin
US6300367B1 (en) * 1999-04-20 2001-10-09 Protein Technologies International, Inc. Composition for and method of preventing or treating breast cancer
US6555551B1 (en) * 1999-08-31 2003-04-29 Mutual Pharmaceutical Co., Inc. Stable formulations of ACE inhibitors, and methods for preparation thereof
AR029538A1 (es) * 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos

Also Published As

Publication number Publication date
DOP2002000389A (es) 2002-11-30
US20030004182A1 (en) 2003-01-02
MA27017A1 (fr) 2004-12-20
HUP0401391A2 (hu) 2004-12-28
DE60221238T2 (de) 2007-10-31
DK1383482T3 (da) 2007-10-29
PA8544401A1 (es) 2003-07-28
NZ528886A (en) 2005-04-29
UA75135C2 (en) 2006-03-15
WO2002087546A2 (en) 2002-11-07
UY27277A1 (es) 2002-11-29
GEP20053654B (en) 2005-11-10
EE200300537A (et) 2004-04-15
ATE367152T1 (de) 2007-08-15
OA12596A (en) 2006-06-08
BG108297A (bg) 2005-07-29
EP1383482A2 (en) 2004-01-28
US7176221B2 (en) 2007-02-13
CA2445519A1 (en) 2002-11-07
MXPA03009391A (es) 2004-01-29
SK13552003A3 (sk) 2004-09-08
US7037530B2 (en) 2006-05-02
TWI264311B (en) 2006-10-21
AR033288A1 (es) 2003-12-10
ZA200307819B (en) 2004-10-07
WO2002087546A3 (en) 2003-02-13
SK286536B6 (sk) 2008-12-05
TNSN03106A1 (fr) 2005-12-23
EA200301040A1 (ru) 2004-04-29
ES2286226T3 (es) 2007-12-01
DE60221238D1 (de) 2007-08-30
HK1065705A1 (en) 2005-03-04
KR100568380B1 (ko) 2006-04-05
EP1383482B1 (en) 2007-07-18
CN1531423A (zh) 2004-09-22
NO20034709L (no) 2003-10-31
PL366453A1 (en) 2005-02-07
NO20034709D0 (no) 2003-10-21
KR20040015226A (ko) 2004-02-18
CN1240375C (zh) 2006-02-08
US20060093667A1 (en) 2006-05-04
HUP0401391A3 (en) 2009-06-29
IS6985A (is) 2003-10-09
BR0209283A (pt) 2004-07-13
CZ20032959A3 (cs) 2004-01-14
GT200200078A (es) 2003-01-31
PE20021137A1 (es) 2002-12-14
ECSP034826A (es) 2004-02-26
AU2002236166B2 (en) 2006-12-07
JP2004531537A (ja) 2004-10-14
PT1383482E (pt) 2007-09-20
AP2003002900A0 (en) 2003-12-31
IL158390A0 (en) 2004-05-12
HRP20030858A2 (en) 2005-08-31
EA005949B1 (ru) 2005-08-25
CA2445519C (en) 2009-01-20

Similar Documents

Publication Publication Date Title
TWI264311B (en) Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency
UA84266C2 (uk) Дозована лікарська форма у вигляді таблетки або пелети для перорального введення, яка містить інгібітор pde 4 та полівінілпіролідон, способи її одержання та застосування
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
SI1746980T1 (sl) Farmacevtska dozirna oblika ki obsega pelete kot tudi postopek za njeno pripravo
HUP0302131A2 (hu) Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények
AP1954A (en) Controlled release compositions comprising nimesulide.
CA2489407A1 (en) Lasofoxifene tablet and its coating
PT1412384E (pt) Formulação estável de glp-1 modificado
ATE206304T1 (de) Bioadhesive feste arzneimittelform
PL334656A1 (en) Dosage forms and methods of achieving betterement in cases of erection disorderamong male patients
TW200630123A (en) Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
TW200503775A (en) Pharmaceutical composition and method for treating
AU3846901A (en) Oral, nasal and pulmonary dosage formualtions of copolymer 1
AU2002231654A1 (en) Pharmaceutical paste comprising an acid-labile active ingredient
IL154210A0 (en) Methods and pharmaceutical compositions for healing wounds
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
WO2002011694A3 (en) COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS
SE0102440D0 (sv) New compound
IL150528A0 (en) Ibuprofen containing active agent preparation
HUP0203717A2 (hu) Izotretinoint tartalmazó új biológiailag hasznos gyógyszerkészítmény és eljárás az előállítására
WO2002056867A3 (en) Extended release pharmaceutical compositions containing beta-lactam antibiotics
AR033331A1 (es) Formas polimorfas de un citrato de azabiciclo [2,2,2] octan-3-amina, sus composiciones farmaceuticas, procedimiento de tratamiento y procedimiento para su produccion.
MY145885A (en) Controlled release formulations for oral administration